MAFLD with central obesity is associated with increased risk of colorectal adenoma and high-risk adenoma
- PMID: 38649845
- PMCID: PMC11034043
- DOI: 10.1186/s12876-024-03220-z
MAFLD with central obesity is associated with increased risk of colorectal adenoma and high-risk adenoma
Abstract
Objective: To analyze the risk factors associated with colorectal adenoma and to investigate the associations of metabolism-related fatty liver disease (MAFLD) with obesity, colorectal adenoma and high-risk adenoma.
Methods: A total of 1395 subjects were enrolled and divided into a colorectal adenoma group (593 subjects) and a control group (802 subjects) according to the inclusion and exclusion criteria. The characteristics of patients in the colorectal adenoma group and the control group were compared by the chi-square test. Univariate and multivariate logistic analyses were used to analyze independent risk factors and associations with different MAFLD subtypes. Colorectal adenoma characteristics and the proportion of patients with high-risk colorectal adenoma were also compared.
Results: High-density lipoprotein (HDL-C) was significantly lower in patients in the colorectal adenoma group than in those in the control group (P < 0.001). Logistic regression analysis revealed that age, obesity status, central obesity status, hypertension status, diabetes status, fatty liver status, smoking history, BMI, waist circumference, triglyceride level, HDL-C level, fasting blood glucose level and degree of hepatic steatosis were all independent risk factors for colorectal adenoma. Notably, MAFLD was associated with a significantly increased risk of colorectal adenoma in patients with central obesity (P < 0.001). In addition, obesity, central obesity, diabetes, fatty liver and degree of hepatic steatosis were all shown to be independent risk factors for high-risk colorectal adenoma. In addition, a greater proportion of MAFLD patients with central obesity than those without central obesity had high-risk colorectal adenoma.
Conclusion: MAFLD and central obesity are independently associated with the development of colorectal adenoma. MAFLD with central obesity is associated with an increased risk of colorectal adenoma and high-risk adenoma.
Keywords: Central obesity; Colorectal adenoma; High-risk adenoma; MAFLD.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Similar articles
-
Obesity-related parameters and colorectal adenoma development.J Gastroenterol. 2017 Dec;52(12):1221-1229. doi: 10.1007/s00535-017-1319-0. Epub 2017 Feb 14. J Gastroenterol. 2017. PMID: 28197803
-
Non-Obese MAFLD Is Associated with Colorectal Adenoma in Health Check Examinees: A Multicenter Retrospective Study.Int J Mol Sci. 2021 May 22;22(11):5462. doi: 10.3390/ijms22115462. Int J Mol Sci. 2021. PMID: 34067258 Free PMC article.
-
Visceral obesity and insulin resistance as risk factors for colorectal adenoma: a cross-sectional, case-control study.Am J Gastroenterol. 2010 Jan;105(1):178-87. doi: 10.1038/ajg.2009.541. Epub 2009 Sep 15. Am J Gastroenterol. 2010. PMID: 19755965
-
An association between colonic adenoma and abdominal obesity: a cross-sectional study.BMC Gastroenterol. 2009 Jan 15;9:4. doi: 10.1186/1471-230X-9-4. BMC Gastroenterol. 2009. PMID: 19144203 Free PMC article.
-
Metabolic-associated fatty liver disease is associated with colorectal adenomas in young and older Korean adults.Liver Int. 2023 Nov;43(11):2548-2559. doi: 10.1111/liv.15738. Epub 2023 Sep 22. Liver Int. 2023. PMID: 37735984
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical